4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-028975
Director sold 26,000 shares at $36.54 ($950,040)
From the SEC's structured data for this filing
Trades in this filing
Waddill William D. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-11 | Sale : show line 1 in the form | −26,000 | $36.54 | $950,040 | 28,000 | D |
| Open-market sales · 26,000 sh · avg $36.54 · $950,040 | ||||||
Loading xslF345X03/doc4.xml…